IIB 
114TH CONGRESS 
2D SESSION 
H. R. 3537 
IN THE SENATE OF THE UNITED STATES 
SEPTEMBER 27, 2016 
Received; read twice and referred to the Committee on the Judiciary 
AN ACT 
To amend the Controlled Substances Act to add certain 
synthetic substances to schedule I, and for other purposes. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
VerDate Sep 11 2014 
22:28 Sep 27, 2016
Jkt 059200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H3537.RFS
H3537
asabaliauskas on DSK3SPTVN1PROD with BILLS
HR 3537 RFS
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘Dangerous Synthetic 
Drug Control Act of 2016’’. 
SEC. 2. TREATMENT OF CERTAIN DESIGNER DRUGS AS 
SCHEDULE I CONTROLLED SUBSTANCES. 
(a) CANNABIMIMETIC AGENTS.—Schedule I, as set 
forth in section 202(c) of the Controlled Substances Act 
(21 U.S.C. 812(c)), is amended in subsection (d)(2)(B)— 
(1) in clause (xiv) by striking ‘‘and’’ at the end; 
(2) in clause (xv) by striking the period and in-
serting a semicolon; and 
(3) by adding at the end the following: 
‘‘(xvi) 2-(2-methylphenyl)-1-(1-pentyl-1H- 
indol-3-yl)ethanone (JWH–251); 
‘‘(xvii) 
(1-butyl-1H-indol-3-yl)(4- 
methylnaphthalen-1-yl)methanone 
(4′-methyl 
JWH–073); 
‘‘(xviii) 
2-(3-methoxyphenyl)-1-(1-pentyl- 
1H-indol-3-yl)ethanone (JWH–302); 
‘‘(xix) 
N-(adamantan-1-yl)-1-(5- 
fluoropentyl)-1H-indole-3-carboxamide 
(5F– 
APICA); 
‘‘(xx) quinolin-8-yl 1-(5-fluoropentyl)-1H- 
indole-3-carboxylate (5F–PB–22); 
VerDate Sep 11 2014 
22:28 Sep 27, 2016
Jkt 059200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H3537.RFS
H3537
asabaliauskas on DSK3SPTVN1PROD with BILLS
HR 3537 RFS
‘‘(xxi) N-(1-amino-3-methyl-1-oxobutan-2- 
yl)-1-pentyl-1H-indazole-3-carboxamide 
(AB– 
PINACA); 
‘‘(xxii) 
N-(naphthalen-1-yl)-1-pentyl-1H- 
indole-3-carboxamide (MN–24); 
‘‘(xxiii) 
(1-(5-fluoropentyl)-1H-indazol-3- 
yl)(naphthalen-1-yl)methanone (THJ–2201); 
‘‘(xxiv) 
N-(1-amino-3,3-dimethyl-1- 
oxobutan-2-yl)-1-pentyl-1H-indazole-3- 
carboxamide (ADBICA); 
‘‘(xxv) methyl 2-(1-(5-fluoropentyl)-1H-in-
dazole-3-carboxamido)-3-methylbutanoate (5F– 
AMB); and 
‘‘(xxvi) methyl 2-(1-(cyclohexylmethyl)-1H- 
indazole-3-carboxamido)-3-methylbutanoate 
(MA–CHMINACA).’’. 
(b) SYNTHETIC OPIOIDS.—Schedule I, as set forth in 
section 202(c) of the Controlled Substances Act (21 
U.S.C. 812(c)), is amended in subsection (a) by adding 
at the end the following: 
‘‘(43) Butyryl fentanyl. 
‘‘(44) beta-Hydroxythiofentanyl. 
‘‘(45) Acetyl fentanyl.’’. 
(c) OTHER DRUGS.—Schedule I, as set forth in sec-
tion 202(c) of the Controlled Substances Act (21 U.S.C. 
VerDate Sep 11 2014 
22:28 Sep 27, 2016
Jkt 059200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\H3537.RFS
H3537
asabaliauskas on DSK3SPTVN1PROD with BILLS
HR 3537 RFS
812(c)), is amended in subsection (c) by adding at the 
end the following: 
‘‘(29) 
1-(naphthalen-1-yl)-2-(pyrrolidin-1- 
yl)pentan-1-one (α-naphyrone). 
‘‘(30) 
1-(2,3-dihydrobenzofuran-5-yl)propan-2- 
amine (5–APDB). 
‘‘(31) 
1-(2,3-dihydrobenzofuran-6-yl)propan-2- 
amine (6–APDB). 
‘‘(32) 6,7-dihydro-5H-indeno[5,6-d][1,3]dioxol- 
6-amine (MDAI). 
‘‘(33) 5-iodo-2,3-dihydro-1H-inden-2-amine (5– 
IAI). 
‘‘(34) 
1-(4-bromofuro[2,3-f]benzofuran-8- 
yl)propan-2-amine (bromo-dragonfly). 
‘‘(35) 1-(4-chloro-2,5-dimethoxyphenyl)propan- 
2-amine (DOC). 
‘‘(36) 1-(4-ethoxy-2,5-dimethoxyphenyl)propan- 
2-amine (MEM).’’. 
Passed the House of Representatives September 26, 
2016. 
Attest: 
KAREN L. HAAS, 
Clerk. 
VerDate Sep 11 2014 
22:28 Sep 27, 2016
Jkt 059200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6201
E:\BILLS\H3537.RFS
H3537
asabaliauskas on DSK3SPTVN1PROD with BILLS